News

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...
Mouse models treated with the sleep aid lemborexant had less brain damage compared to controls and mice that received a different sleep drug.
The latest imaging method from the Broad Institute uncovers structural disruptions in the nucleus associated with progeria at ...
Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.
BioAgilytix officials say the company's expansion strengthens its ability to support biopharma partners at every stage of ...
Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular ...
A scientist says he has shown that it’s possible to produce a large amount of virus-like particles using a fully scalable ...
Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...
The increased genetic complexity and similarity to adult cancers’ genetic diversity could also present new therapeutic opportunities.
Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...
The first systematic genome-wide association study for pseudogout has identified two genes strongly associated with disease ...
How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...